National Instruments Logo

Print Print page   Email Email page   PDF Download PDF    Add to Briefcase
« Previous Release | Next Release »



National Instruments Reports Record Third Quarter Revenue

Company guides to record quarterly revenue in Q4 and over $1 billion in revenue for 2011

Oct 26, 2011 04:01 PM Eastern Daylight Time

AUSTIN, Texas, Oct. 26, 2011 /PRNewswire/ --

Q3 2011 Highlights


National Instruments (Nasdaq: NATI) today announced Q3 revenue of $255 million, a quarterly record and a 16 percent increase from Q3 2010.  Non-GAAP revenue for Q3 was $271 million, up 23 percent from Q3 2010.  In Q3, the Company's orders greater than $20,000 grew 31 percent year-over-year, and the average order size reached a new all-time record of approximately $4,600.

For Q3, the Company had two adjustments between GAAP and non-GAAP revenue.  The first is for $3 million and relates to the acquisition accounting for deferred revenue for our AWR acquisition.  This adjustment was included in the guidance we gave for Q3. The second adjustment was not included in our guidance and is for a $13 million accrual which was recorded in Q3 and is related to a dispute concerning our GSA contract with the U.S. Government.  The Company terminated this contract with the GSA effective May 2011.  This accrual represents the amount of the loss contingency that is reasonably estimable at this time.   This dispute was discussed in our form 10-Qs filed in both April 2011 and July 2011.  

Net income for Q3 was $12.7 million, with fully diluted earnings per share (EPS) of $0.11, and non-GAAP net income was $31.0 million, with non-GAAP fully diluted EPS of $0.26.  

In Q3, GAAP gross margin decreased 210 basis points year-over-year to 74.4 percent. Non-GAAP gross margin remained flat at 77.0 percent.

The company's non-GAAP results exclude the impact of stock-based compensation, amortization of acquisition-related intangibles, acquisition accounting for deferred revenue, adjustments related to our contract dispute with the GSA and acquisition related transaction costs. Reconciliations of the company's GAAP and non-GAAP results are included as part of this news release.

"Over the last few years we have invested significantly in building out our capabilities to serve our larger customers, which enabled the significant progress we saw in Q3," said Dr. James Truchard, co-founder, president and CEO.  "This ability to grow our larger orders will be key to achieving our goal of $2 billion in revenue by 2016."  

NI graphical system design product sales were up 24 percent year-over-year, and NI instrument control product sales were up 1 percent year-over-year in Q3. Geographically, revenue in U.S. dollar terms for Q3 2011 compared to Q3 2010 was up 2 percent in the Americas, up 25 percent in Europe and up 28 percent in Asia. In local currency terms, revenue was up 14 percent in Europe and up 19 percent in Asia. In Q3, revenue in the Americas was negatively impacted by the $13 million accrual related to our GSA contract.

As of September 30, 2011, NI had $336 million in cash and short-term investments. The National Instruments Board of Directors approved a quarterly dividend of $0.10 per share on the company's common stock payable on November 28 to stockholders of record on November 7.

"We have exercised good discipline this year in matching expense growth to revenue growth, with non-GAAP revenue up 22% and non-GAAP operating expenses up by 23%, year to date, and delivering a record $120 million in non-GAAP operating income for the first nine months," said Davern. "While we are cautious about the direction of the industrial economy over the coming quarters, we are confident our investments will significantly advance our long-term position in the industries we serve."

Guidance for Q4 2011

With the Global PMI dipping below 50 in September, we did see the significant decline in Q3 that we had anticipated when giving guidance.  Looking forward, we anticipate further weakness in the industrial economy in Q4 and as a result, we are taking a conservative approach to guidance for Q4, guiding to a midpoint of 8% sequential growth, below the historical seasonal average.

NI expects revenue for Q4 to be between $280 million and $300 million, an increase of between 12 and 20 percent over Q4 2010. Due to the impact of the acquisition accounting for the AWR transaction, we are also including guidance for non-GAAP revenue to reflect the write-down of AWR's historical deferred revenue to the fair value recorded as a result of acquisition accounting. As a result, we expect non-GAAP revenue to be in the range of $282 and $302 million, an increase of between 13 percent and 21 percent over Q4 2010.  

Given that we are closing out our 2011 investment plan, we expect to see a very modest increase in operating expenses in Q4.  Looking out to 2012, our objective will be to grow revenues faster than expenses and we believe we will be able to achieve this goal if we are able to deliver year-over-year revenue growth in the high single digit range or better.

The company expects fully diluted EPS will be in the range of $0.22 to $0.30 for Q4, with non-GAAP fully diluted EPS expected to be in the range of $0.29 to $0.37.  Please remember that in Q4 the GAAP to Non-GAAP adjustments will include a $0.03 per share adjustment related to the acquisitions of AWR and Phase Matrix.

Non-GAAP Presentation

In addition to disclosing results determined in accordance with GAAP, NI discloses certain non-GAAP operating results and non-GAAP information that exclude certain charges. In this news release, the company has presented its net sales, gross profit, operating expenses, operating income, income before income taxes, provision for (benefit from) income taxes, net income and basic and fully diluted EPS for the three-month and nine-month periods ended September 30, 2011 and 2010, on a GAAP and non-GAAP basis. We are also providing guidance on our non-GAAP revenue and non-GAAP fully diluted EPS.  When presenting non-GAAP information, the company includes a reconciliation of the non-GAAP results to the GAAP results. Management believes that including the non-GAAP results assists investors in assessing the company's operational performance and its performance relative to its competitors. The company presents these non-GAAP results as a complement to results provided in accordance with GAAP, and these results should not be regarded as a substitute for GAAP. Management uses these non-GAAP measures to manage and assess the profitability and performance of its business and does not consider stock-based compensation, amortization of acquisition-related intangibles, acquisition accounting for deferred revenue, adjustments related to our contract dispute with the GSA and acquisition related transaction costs in managing its operations. Specifically, management uses non-GAAP measures to plan and forecast future periods, to establish operational goals, to compare with its business plan and individual operating budgets, to measure management performance for the purposes of executive compensation including payments to be made under bonus plans, to assist the public in measuring the company's performance relative to the company's long-term public performance goals, to allocate resources and, relative to the company's historical financial performance, to enable comparability between periods. Management also considers such non-GAAP results to be an important supplemental measure of its performance.

This news release also discloses the company's earnings before interest, taxes, depreciation and amortization (EBITDA) and EBITDA diluted EPS for the three-month and nine-month periods ended September 30, 2011 and 2010. The company also believes that including the EBITDA results assists investors in assessing the company's operational performance relative to its competitors. A reconciliation of EBITDA and EBITDA diluted EPS to GAAP net income and GAAP diluted EPS is included with this news release.

Conference Call Information

Interested parties can listen to the Q3 2011 conference call today, October 26, beginning at 4:00 p.m. CDT, at www.ni.com/call. Replay information is available by calling 888-203-1112, confirmation code #7506942, shortly after the call through October 31 at 7:00 p.m. CDT.

Forward-Looking Statements

This release contains "forward-looking statements," including statements related to the strength of our business model, commitments to long-term investments, the scale of the long-term opportunity open to us, being cautious about the direction of the industrial economy, being confident our investments will significantly advance our long-term position, very modest increase in non-GAAP operating expenses, growing revenues faster than expenses and being able to achieve such a goal and our Q4 guidance for GAAP and non-GAAP revenue (including our non-GAAP revenue adjustment) and GAAP and non-GAAP EPS. These statements are subject to a number of risks and uncertainties, including the risk of adverse changes or fluctuations in the global economy, component shortages, delays in the release of new products, fluctuations in customer demand for NI products, the company's ability to effectively manage its operating expenses, manufacturing inefficiencies, foreign exchange fluctuations, the outcome of our dispute with the U.S. government on our GSA contract, and the impact of our recent and any future acquisitions. Actual results may differ materially from the expected results. The company directs readers to its Form 10-K for the fiscal year ended Dec. 31, 2010, its Form 10-Q for the quarter ended June 30, 2011, and the other documents it files with the SEC for other risks associated with the company's future performance.

About National Instruments

National Instruments (www.ni.com) is transforming the way engineers and scientists design, prototype and deploy systems for measurement, automation and embedded applications. NI empowers customers with off-the-shelf software such as NI LabVIEW and modular cost-effective hardware, and sells to a broad base of more than 30,000 different companies worldwide, with its largest customer representing approximately 4 percent of revenue in 2010 and no one industry representing more than 15 percent of revenue. Headquartered in Austin, Texas, NI has approximately 6,130 employees and direct operations in more than 40 countries. For the past 12 years, FORTUNE magazine has named NI one of the 100 best companies to work for in America. Readers can obtain investment information from the company's investor relations department by calling (512) 683-5090, e-mailing nati@ni.com or visiting www.ni.com/nati. (NATI-F)

CompactRIO, LabVIEW, National Instruments, NI and ni.com are trademarks of National Instruments. Other product and company names listed are trademarks or trade names of their respective companies.


Contact

Caitlin Cooper Gursslin


Investor Relations


(512) 683-8456





National Instruments

Consolidated Balance Sheets

(in thousands)








September 30,


December 31,



2011


2010



(unaudited)








Assets





Current assets:





Cash and cash equivalents

$

196,511

$

219,447

Short-term investments


139,372


131,215

Accounts receivable, net


158,608


127,214

Inventories, net


132,554


117,765

Prepaid expenses and other current assets


46,068


36,239

Deferred income taxes, net


16,122


18,838

Total current assets


689,235


650,718






Property and equipment, net


182,300


160,410

Goodwill


131,353


70,278

Intangible assets, net


90,142


52,816

Other long-term assets


22,649


25,460

Total assets

$

1,115,679

$

959,682






Liabilities and Stockholders' Equity





Current liabilities:





Accounts payable

$

39,650

$

33,544

Accrued compensation


38,444


27,734

Deferred revenue


83,336


71,650

Accrued expenses and other liabilities


35,290


16,538

Other taxes payable


22,117


16,846

Total current liabilities


218,837


166,312






Deferred income taxes


36,413


29,477

Liability for uncertain tax positions


15,376


14,953

Other long-term liabilities


18,255


4,395

Total liabilities

$

288,881

$

215,137






Stockholders' equity:





Preferred stock


-


-

Common stock


1,204


1,179

Additional paid-in capital


459,486


407,713

Retained earnings


370,211


336,363

Accumulated other comprehensive (loss)


(4,103)


(710)

Total stockholders' equity

$

826,798

$

744,545

Total liabilities and stockholders' equity

$

1,115,679

$

959,682





National Instruments

Consolidated Statements of Income

(in thousands, except per share data)












Three Months Ended


Nine Months Ended



September 30,


September 30,



(Unaudited)


(Unaudited)



2011


2010


2011


2010

Net sales:









Product

$

247,256

$

203,188

$

699,007

$

573,413

Software maintenance


20,839


17,261


60,222


49,844

GSA Accrual


(13,107)


-


(13,107)


-

Total net sales


254,988


220,449


746,122


623,257










Cost of sales:









Product

$

63,579

$

50,380

$

169,340

$

139,818

Software maintenance


1,636


1,523


4,237


3,966

Total cost of sales


65,215


51,903


173,577


143,784










Gross profit

$

189,773

$

168,546

$

572,545

$

479,473










Operating expenses:









Sales and marketing

$

103,195

$

79,494

$

286,547

$

233,166

Research and development


54,674


39,971


144,569


114,912

General and administrative


21,148


17,392


61,219


49,701

Total operating expenses

$

179,017

$

136,857

$

492,335

$

397,779










Operating income

$

10,756

$

31,689

$

80,210

$

81,694










Other income (expense):









Interest income

$

354

$

380

$

1,039

$

1,051

Net foreign exchange gain (loss)


(708)


426


(1,417)


(2,475)

Other income (expense), net


(95)


160


(220)


970










Income before income taxes

$

10,307

$

32,655

$

79,612

$

81,240










Provision for (benefit from) income taxes


(2,429)


4,522


9,867


10,152










Net income

$

12,736

$

28,133

$

69,745

$

71,088










Basic earnings per share

$

0.11

$

0.24

$

0.58

$

0.61

Diluted earnings per share

$

0.11

$

0.24

$

0.58

$

0.60










Weighted average shares outstanding -









basic


120,308


117,264


119,585


116,748

diluted


121,102


118,293


121,027


118,272










Dividends declared per share

$

0.10

$

0.09

$

0.30

$

0.26





National Instruments

Consolidated Statements of Cash Flows

(in thousands)



Nine Months Ended



September 30,



(Unaudited)



2011


2010

Cash flow from operating activities:





Net income

$

69,745

$

71,088

Adjustments to reconcile net income to net cash provided





by operating activities:





Depreciation and amortization


35,745


28,220

Stock-based compensation


16,650


14,194

Tax (benefit) expense from deferred income taxes


(491)


1,174

Tax (benefit) expense from stock option plans


(5,047)


599

Changes in operating assets and liabilities:





Accounts receivable


(23,509)


(17,298)

Inventories


(12,376)


(14,712)

Prepaid expenses and other assets


(9,000)


(15,328)

Accounts payable


4,112


9,171

Deferred revenue


10,215


6,698

Taxes and other liabilities


30,456


33,938

Net cash provided by operating activities

$

116,500

$

117,744






Cash flow from investing activities:





Capital expenditures


(40,329)


(14,404)

Capitalization of internally developed software


(11,412)


(14,300)

Additions to other intangibles


(3,226)


(2,253)

Acquisitions, net of cash received


(73,558)


(2,191)

Purchases of short-term investments


(93,299)


(88,226)

Sales and maturities of short-term investments


86,086


63,519

Net cash (used by) investing activities

$

(135,738)

$

(57,855)






Cash flow from financing activities:





Proceeds from issuance of common stock


27,152


38,368

Repurchase of common stock


-


(41,862)

Dividends paid


(35,897)


(30,417)

Tax benefit (expense)  from stock option plans


5,047


(599)

Net cash (used by) financing activities

$

(3,698)

$

(34,510)






Net change in cash and cash equivalents


(22,936)


25,379

Cash and cash equivalents at beginning of period


219,447


201,465

Cash and cash equivalents at end of period

$

196,511

$

226,844





Detail of GAAP charges related to revenue, stock-based compensation,

amortization of acquisition intangibles and acquisition related transaction costs

(Unaudited)












Three Months Ended


Nine Months Ended



September 30,


September 30,



2011


2010


2011


2010

Revenue









Acquisition related deferred revenue

$

2,818

$

-

$

2,818

$

-

GSA accrual


13,107


-


13,107


-

Provision for (benefit from) income taxes


(5,573)


-


(5,573)


-

Total

$

10,352

$

-

$

10,352

$

-










Stock-based compensation









Cost of sales

$

401

$

332

$

1,116

$

1,014

Sales and marketing


2,630


1,960


7,009


6,060

Research and development


2,489


1,771


6,245


5,129

General and administrative


834


672


2,280


1,991

Provision for (benefit from) income taxes


(826)


(1,295)


(4,786)


(4,422)

Total

$

5,528

$

3,440

$

11,864

$

9,772










Amortization of acquisition intangibles









Cost of sales

$

2,586

$

921

$

4,595

$

2,565

Sales and marketing


447


89


624


311

Other income (expense), net


198


-


765


-

Provision for (benefit from) income taxes


(1,034)


(324)


(1,743)


(904)

Total

$

2,197

$

686

$

4,241

$

1,972










Acquisition related transaction costs









Cost of sales

$

22

$

-

$

22

$

-

Sales and marketing


147


-


1,129


-

Research and development


70


-


70


-

General and administrative


31


-


458


-

Provision for (benefit from) income taxes


(95)


-


(146)


-

Total

$

175

$

-

$

1,533

$

-





National Instruments

Reconciliation of GAAP to Non-GAAP Measures

(in thousands, except per share data)

(unaudited)












Three Months Ended


Nine Months Ended



September 30,


September 30,



2011


2010


2011


2010

Reconciliation of Net Sales to Non-GAAP Net Sales










Net sales, as reported

$

254,988

$

220,449

$

746,122

$

623,257

Acquisition related deferred revenue


2,818


-


2,818


-

GSA Accrual


13,107


-


13,107


-

Non-GAAP Net sales

$

270,913

$

220,449

$

762,047

$

623,257

Reconciliation of Gross Profit to Non-GAAP Gross Profit










Gross profit, as reported

$

189,773

$

168,546

$

572,545

$

479,473

Acquisition related deferred revenue and GSA accrual


15,925


-


15,925


-

Stock-based compensation


401


332


1,116


1,014

Amortization of acquisition intangibles


2,586


921


4,595


2,565

Acquisition related transaction costs


22


-


22


-

Non-GAAP gross profit

$

208,707

$

169,799

$

594,203

$

483,052

Reconciliation of Operating Expenses to Non-GAAP Operating Expenses










Operating expenses, as reported

$

179,017

$

136,857

$

492,335

$

397,779

Stock-based compensation


(5,953)


(4,403)


(15,534)


(13,180)

Amortization of acquisition intangibles


(447)


(89)


(624)


(311)

Acquisition related transaction costs


(248)


-


(1,657)


-

Non-GAAP operating expenses

$

172,369

$

132,365

$

474,520

$

384,288

Reconciliation of Operating Income to Non-GAAP Operating Income










Operating income, as reported

$

10,756

$

31,689

$

80,210

$

81,694

Acquisition related deferred revenue and GSA accrual


15,925


-


15,925


-

Stock-based compensation


6,354


4,735


16,650


14,194

Amortization of acquisition intangibles


3,033


1,010


5,219


2,876

Acquisition related transaction costs


270


-


1,679


-

Non-GAAP operating income

$

36,338

$

37,434

$

119,683

$

98,764

Reconciliation of Income before income taxes to Non-GAAP Income before income taxes










Income before income taxes, as reported

$

10,307

$

32,655

$

79,612

$

81,240

Acquisition related deferred revenue and GSA accrual


15,925


-


15,925


-

Stock-based compensation


6,354


4,735


16,650


14,194

Amortization of acquisition intangibles


3,231


1,010


5,984


2,876

Acquisition related transaction costs


270


-


1,679


-

Non-GAAP income before provision for (benefit from) income taxes

$

36,087

$

38,400

$

119,850

$

98,310

Reconciliation of Provision For (Benefit From) Income Taxes to Non-GAAP Provision For (Benefit From) Income Taxes










Provision for (benefit from) income taxes, as reported

$

(2,429)

$

4,522

$

9,867

$

10,152

Acquisition related deferred revenue and GSA accrual  


5,573


-


5,573


-

Stock-based compensation


826


1,295


4,786


4,422

Amortization of acquisition intangibles


1,034


324


1,743


904

Acquisition related transaction costs


95


-


146


-

Non-GAAP provision for (benefit from) income taxes

$

5,099

$

6,141

$

22,115

$

15,478





Reconciliation of GAAP Net Income, Basic EPS and Diluted EPS to Non-GAAP Net Income, Basic EPS and Diluted EPS

(unaudited)












Three Months Ended


Nine Months Ended



September 30,


September 30,



2011


2010


2011


2010

Net income, as reported

$

12,736

$

28,133

$

69,745

$

71,088

Adjustments to reconcile net income to non-GAAP net income:









 Acquisition related deferred revenue and GSA accrual, net of tax effect


10,352


-


10,352


-

 Stock-based compensation, net of tax effect


5,528


3,440


11,864


9,772

 Amortization of acquisition intangibles, net of tax effect


2,197


686


4,241


1,972

 Acquisition related transaction costs


175


-


1,533


-

Non-GAAP net income

$

30,988

$

32,259

$

97,735

$

82,832










Basic EPS, as reported

$

0.11

$

0.24

$

0.58

$

0.61

Adjustment to reconcile basic EPS to non-GAAP









basic EPS:









 Revenue, net of tax effect

$

0.09

$

-

$

0.09

$

-

 Impact of stock-based compensation, net of tax effect

$

0.04

$

0.03

$

0.10

$

0.08

 Impact of amortization of acquisition intangibles, net of tax effect

$

0.02

$

0.01

$

0.04

$

0.02

 Impact of acquisition related transaction costs

$

0.00

$

-

$

0.01

$

-

Non-GAAP basic EPS

$

0.26

$

0.28

$

0.82

$

0.71



















Diluted EPS, as reported

$

0.11

$

0.24

$

0.58

$

0.60

Adjustment to reconcile diluted EPS to non-GAAP









diluted EPS:









 Acquisition related deferred revenue and GSA accrual, net of tax effect

$

0.08

$

-

$

0.09

$

-

 Impact of stock-based compensation, net of tax effect

$

0.05

$

0.03

$

0.10

$

0.08

 Impact of amortization of acquisition intangibles, net of tax effect

$

0.02

$

0.00

$

0.03

$

0.02

 Impact of acquisition related transaction costs

$

0.00

$

-

$

0.01

$

-

Non-GAAP diluted EPS

$

0.26

$

0.27

$

0.81

$

0.70










Weighted average shares outstanding -









Basic


120,308


117,264


119,585


116,748

Diluted


121,102


118,293


121,027


118,272





Reconciliation of Net Income and Diluted EPS to EBITDA and EBITDA Diluted EPS

(unaudited)












Three Months Ended


Nine Months Ended



September 30,


September 30,



2011


2010


2011


2010

Net income, as reported

$

12,736

$

28,133

$

69,745

$

71,088

Adjustments to reconcile net income to EBITDA:









    Interest income


(354)


(380)


(1,039)


(1,051)

    Taxes


(2,429)


4,522


9,867


10,152

    Depreciation and amortization


12,355


9,232


35,745


28,220

EBITDA

$

22,308

$

41,507

$

114,318

$

108,409










Diluted EPS, as reported

$

0.11

$

0.24

$

0.58

$

0.60

Adjustment to reconcile diluted EPS to EBITDA









    Interest income

$

(0.01)

$

(0.00)

$

(0.01)

$

(0.01)

    Taxes

$

(0.02)

$

0.03

$

0.08

$

0.09

    Depreciation and amortization

$

0.10

$

0.08

$

0.29

$

0.24

EBITDA diluted EPS

$

0.18

$

0.35

$

0.94

$

0.92










Weighted average shares outstanding - Diluted


121,102


118,293


121,027


118,272





National Instruments

Reconciliation of GAAP to Non-GAAP Guidance

(unaudited)










Three months ended




December 31, 2011




(Millions)




Low


High

GAAP revenue, guidance

$

280

$

300

Adjustment to reconcile revenue to non-GAAP revenue;





  Impact of acquisition deferred revenue write down

$

2

$

2







Non-GAAP revenue, guidance

$

282

$

302




















National Instruments

Reconciliation of GAAP to Non-GAAP EPS Guidance

(unaudited)










Three months ended




December 31, 2011




Low


High

GAAP Fully Diluted EPS, guidance

$

0.22

$

0.30

Adjustment to reconcile diluted EPS to non-GAAP





diluted EPS:





 Impact of acquisition deferred revenue write-off

$

0.01

$

0.01

 Impact of stock-based compensation, net of tax effect

$

0.04

$

0.04

 Impact of amortization of acquisition intangibles, net of tax effect

$

0.02

$

0.02







Non-GAAP diluted EPS, guidance

$

0.29

$

0.37




SOURCE National Instruments

News Provided by Acquire Media

Close window | Back to top